NIH × Amplified Fragment Length Polymorphism Analysis × Clear all Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
Phase 2 Completed
73 enrolled 16 charts
Study of a Polymorphism in Patients With Prostate Cancer
Completed
750 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
Unknown
1,800 enrolled
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
Unknown
800 enrolled
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
Phase 1 Unknown
48 enrolled
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Phase NA Unknown
2,200 enrolled
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
Unknown
2,300 enrolled
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Unknown
2,000 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled
Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom
Unknown
2,000 enrolled
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Unknown
2,000 enrolled
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
Unknown
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
Phase 2 Unknown
35 enrolled
CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
Unknown
300 enrolled
Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma
Unknown
2,774 enrolled
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
Unknown
2,000 enrolled
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
Unknown
60 enrolled
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
Unknown
6,000 enrolled
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
Phase 2 Unknown
60 enrolled
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
Unknown
400 enrolled
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery
Phase 3 Completed
3,400 enrolled
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
Unknown
10,000 enrolled
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
Unknown
513 enrolled
Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia
Phase 1 Completed
20 enrolled